GO
Loading...

Health Care Equipment

More

  • Boston Scientific and Fossil are big market movers Wednesday, 18 Feb 2015 | 4:31 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:. Boston Scientific Corp., up $1.84 to $16.68. The medical device maker will pay $600 million as part of a settlement with Johnson& Johnson over the 2006 purchase of Guidant Corp..

  • Midday Glance: Medical Devices companies Wednesday, 18 Feb 2015 | 1:18 PM ET

    Allergan fell $2.74 or 1.2 percent, to $227.41. Baxter International Inc. fell $1.81 or 2.6 percent, to $67.98. Boston Scientific Corp. rose $1.66 or 11.2 percent, to $16.50.

  • Early Glance: Medical Devices companies Wednesday, 18 Feb 2015 | 10:54 AM ET

    Allergan fell $1.80 or. 8 percent, to $228.35. Baxter International Inc. fell $1.02 or 1.5 percent, to $68.77. Boston Scientific Corp. rose $1.53 or 10.3 percent, to $16.37.

  • Final Glance: Medical Devices companies Tuesday, 17 Feb 2015 | 6:10 PM ET

    Allergan rose$. 66 or. 3 percent, to $230.15. Baxter International Inc. fell$. 60 or. 9 percent, to $69.79. Boston Scientific Corp. fell$. 14 or. 9 percent, to $14.84.

  • Feb 17- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson& Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant. J&J had sought more than $7 billion in damages after it lost a bidding war to Boston Scientific following an initial deal to buy Guidant for $21.5...

  • Feb 17- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson& Johnson to settle a long-running breach of merger lawsuit over Boston Scientific's 2005 acquisition of rival Guidant. J&J, which agreed to permanently dismiss its action without acknowledgment of liability by Guidant, had sought more than $7...

  • Midday Glance: Medical Devices companies Tuesday, 17 Feb 2015 | 1:32 PM ET

    Allergan rose$. 54 or. 2 percent, to $230.03. Baxter International Inc. fell$. 68 or 1.0 percent, to $69.71. Boston Scientific Corp. fell$. 14 or 1.0 percent, to $14.84.

  • Early Glance: Medical Devices companies Tuesday, 17 Feb 2015 | 11:00 AM ET

    Allergan rose$. 03 or percent, to $229.52. Baxter International Inc. fell$. 80 or 1.1 percent, to $69.60. Boston Scientific Corp. fell$. 26 or 1.7 percent, to $14.72.

  • Feb 17- Medical device maker Medtronic Plc reported a better-than-expected quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. With sales of $2.22 billion in the third quarter ended Jan. 23, the business accounted for a little over half of overall sales. The company, which completed its acquisition of Ireland-...

  • Medtronic profit rises on higher cardiac device sales Tuesday, 17 Feb 2015 | 7:36 AM ET

    Feb 17- Medical device maker Medtronic Plc reported a 28 percent rise quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. The company, which completed its acquisition of Ireland- based Covidien Plc in January, said its net profit rose to $977 million, or 98 cents per share, for the third quarter ended Jan. 23, from $762...

  • UPDATE 2-Boston Scientific profit beats Street by a cent Wednesday, 4 Feb 2015 | 12:00 PM ET

    *4th- qtr adj/shr $0.22 vs est $0.21. Feb 4- Boston Scientific Corp's adjusted quarterly profit edged past the average analyst estimate and the medical device maker reported a growth in sales for the fifth straight quarter, helped by continued demand for its heart devices. Boston Scientific's sales growth and improving margin have been encouraging in the...

  • Feb 4- Medical device maker Boston Scientific Corp posted a 19 percent fall in fourth-quarter profit as litigation charges more than doubled. Boston Scientific, along with Johnson& Johnson, awaits a New York federal court decision in what could culminate into the final leg of a more than eight-year battle between the two. J&J is seeking more than $7.2 billion in...

  • Boston Scientific profit falls as litigation costs soar Wednesday, 4 Feb 2015 | 7:16 AM ET

    Feb 4- Medical device maker Boston Scientific Corp posted a 19 percent fall in fourth-quarter profit as litigation charges more than doubled. The company's net income fell to $87 million, or 6 cents per share, in the quarter ended Dec. 31 from $108 million, or 8 cents per share, a year earlier. Excluding charges for restructuring, litigation and other costs, the...

  • New crowdfunding index that lists tech disruptors Wednesday, 4 Feb 2015 | 6:00 AM ET

    CNBC Crowdfinance Tech Index lists the largest capital commitments raised by 25 private U.S. tech companies on Crowdnetic’s data platform.

  • *Sanofi struggling to find new CEO in narrow field. PARIS, Jan 30- Barring a last-minute breakthrough, drugs firm Sanofi's Chairman Serge Weinberg may have to acknowledge in his results presentation next week that the hunt for a new chief executive is not going well. Paris- schooled Olivier Bohuon, chief executive of British medical devices maker Smith& Nephew,...

  • Finding opportunities in healthcare  Thursday, 29 Jan 2015 | 5:30 AM ET

    Dan Mahony, fund manager at Polar Capital, tells CNBC how to be a "smart healthcare investor".

  • The rise and rise of life sciences  Thursday, 29 Jan 2015 | 4:55 AM ET

    George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.

  • NEW YORK, Jan 29- When Marty Weinstein decided to quit smoking, he took a friend's advice and tried electronic cigarettes rather than government-approved nicotine replacement products. E-cigarette makers in the United States are barred from explicitly marketing the products as smoking cessation devices, but have found ways to appeal legally to smokers who...

  • Jan 27- Medical device maker Abiomed Inc raised its full-year revenue forecast and said the U.S. Food and Drug Administration had approved its heart pump, sending its stock nearly 32 percent in extended trading. Abiomed's heart pump, Impella RP, helps blood circulation for up to 14 days in patients who develop acute right heart failure following implantation,...

  • Jan 27- Medical device maker Abiomed Inc raised its full-year revenue forecast and said it had received U.S. approval for its heart pump, sending its stock soaring 24 percent after-hours. Abiomed raised its revenue estimate for the year ending March 31 to $223- $226 million from $209- $212 million. The company said the U.S. Food and Drug Administration had approved...